Emergent BioSolutions (EBS) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.85 --0%
EPS Growth %: -31.3%
Financial Fact:
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -31.3%
Financial Fact:
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.78, $0.08 better than the analyst estimate of $0.70. Revenue for the quarter came in at $168.1 million versus the consensus estimate of $168.07 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
